Cite
HARVARD Citation
Lee, W. et al. (2018). ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability. Molecular pain. 14 (1), p. . [Online].